(19)
(11) EP 4 404 857 A1

(12)

(43) Date of publication:
31.07.2024 Bulletin 2024/31

(21) Application number: 22870831.9

(22) Date of filing: 19.09.2022
(51) International Patent Classification (IPC): 
A61B 18/14(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/505; A61K 39/39541; A61P 35/00; C07K 16/2818; A61P 35/04; C07K 2317/76; A61B 2018/00577; A61B 18/1492; A61B 2018/1425
 
C-Sets:
A61K 39/39541, A61K 2300/00;
(86) International application number:
PCT/US2022/044021
(87) International publication number:
WO 2023/044124 (23.03.2023 Gazette 2023/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.09.2021 US 202163246239 P
16.12.2021 US 202163290529 P
22.03.2022 US 202263322319 P
13.06.2022 US 202263351562 P

(71) Applicant: Galvanize Therapeutics, Inc.
Redwood City, CA 94065 (US)

(72) Inventors:
  • O'BRIEN, Timothy, J.
    Redwood City, CA 94065 (US)
  • KRIMSKY, William, S.
    Redwood City, CA 94065 (US)
  • SILVESTRINI, Matthew, T.
    Redwood City, CA 94065 (US)
  • PASTORI, Chiara
    Redwood City, CA 94065 (US)
  • NEAL, Robert, E., II
    Redwood City, CA 94065 (US)
  • WALDSTREICHER, Jonathan, R.
    Redwood City, CA 94065 (US)

(74) Representative: Clark, Jane Anne et al
Mathys & Squire The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY